MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CHRS — Coherus Oncology, Inc. Common Stock
NasdaqCoherus Oncology, Inc. Common Stock
$1.16
+0.00(+0.00%)
- O
- 1.19
- H
- 1.19
- L
- 1.15
- V
- 1.18M
⏱️ End-of-day dataAs of Oct 2, 2026
CHRS — Latest News & Headlines
4 StoriesEligible shareholders may share proceeds from Coherus' assets tied to similar medicines. The sale process has begun. - Stock Titan
Eligible shareholders may share proceeds from Coherus' assets tied to similar medicines. The sale process has begun. Stock Titan
Coherus Oncology Initiates Process to Sell Remaining Legacy Biosimilars Assets, Announces CVR Details - Quiver Quantitative
Coherus Oncology Initiates Process to Sell Remaining Legacy Biosimilars Assets, Announces CVR Details Quiver Quantitative
Coherus Oncology Starts Process to Sell Remaining Biosimilar Assets - Yahoo Finance
Coherus Oncology Starts Process to Sell Remaining Biosimilar Assets Yahoo Finance
Coherus BioSciences stock holds at USD 1.56 after a weak session - AD HOC NEWS
Coherus BioSciences stock holds at USD 1.56 after a weak session AD HOC NEWS